文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

作者信息

Quan Fu-Shi, Compans Richard W, Nguyen Huan H, Kang Sang-Moo

机构信息

Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322.

出版信息

J Virol. 2008 Feb;82(3):1350-9. doi: 10.1128/JVI.01615-07. Epub 2007 Nov 21.


DOI:10.1128/JVI.01615-07
PMID:18032492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2224423/
Abstract

Recovery from live influenza virus infection is known to induce heterosubtypic immunity. In contrast, immunity induced by inactivated vaccines is predominantly subtype specific. In this study, we investigated the heterosubtypic protective immunity induced by inactivated influenza virus. Intranasal immunization of mice with inactivated influenza virus A/PR8 (H1N1) provided complete protection against the homologous virus and a drift virus within the same subtype, A/WSN (H1N1), but not against the heterosubtypic virus A/Philippines (H3N2). However, coadministration of inactivated virus with cholera toxin as an adjuvant conferred complete heterosubtypic protection, without observed illness, even under conditions of CD4(+) or CD8(+) T-cell depletion. Analysis of immune correlates prior to challenge and postchallenge indicated that humoral immune responses with cross-neutralizing activity in lungs and in sera play a major role in conferring protective immunity against heterosubtypic challenge. This study has significant implications for developing broadly cross-reactive vaccines against newly emerging pathogenic influenza viruses.

摘要

相似文献

[1]
Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

J Virol. 2008-2

[2]
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.

Front Immunol. 2019-3-29

[3]
Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Virol J. 2008-3-20

[4]
Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

PLoS One. 2010-11-29

[5]
Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration.

Influenza Other Respir Viruses. 2013-9-16

[6]
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.

PLoS One. 2012-1-27

[7]
Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.

Front Immunol. 2020

[8]
Sublingual vaccination with influenza virus protects mice against lethal viral infection.

Proc Natl Acad Sci U S A. 2008-2-5

[9]
Cationic lipid/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunity.

J Virol. 2010-10-13

[10]
Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.

Immunol Invest. 2020-10

引用本文的文献

[1]
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications.

Pharmaceutics. 2023-1-30

[2]
Synthesis and Characterization of Innovative Microgels Based on Polyacrylic Acid and Microalgae Cell Wall and Their Potential as Antigen Delivery Vehicles.

Pharmaceutics. 2022-12-30

[3]
Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.

J Virol. 2022-10-12

[4]
Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses.

Virology. 2022-9

[5]
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate.

Biomedicines. 2022-5-16

[6]
Protective immunity induced by oral vaccination with a recombinant Lactococcus lactis vaccine against H5Nx in chickens.

BMC Vet Res. 2022-1-3

[7]
Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.

Virology. 2022-1

[8]
Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic.

Nanomaterials (Basel). 2021-7-16

[9]
Application of Nanotechnology in the COVID-19 Pandemic.

Int J Nanomedicine. 2021

[10]
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity.

Vaccines (Basel). 2021-1-21

本文引用的文献

[1]
Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice.

Vaccine. 2007-8-21

[2]
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

J Virol. 2007-4

[3]
Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus.

J Immunol. 2007-1-15

[4]
Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.

Vaccine. 2007-1-4

[5]
Mucosal adjuvants.

Vaccine. 2005-3-7

[6]
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.

J Virol. 2005-3

[7]
Current status of live attenuated influenza virus vaccine in the US.

Virus Res. 2004-7

[8]
Cellular immune responses to influenza.

Dev Biol (Basel). 2003

[9]
Influenza H5 virus escape mutants: immune protection and antibody production in mice.

Virus Res. 2004-2

[10]
Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists.

Clin Diagn Lab Immunol. 2004-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索